腋动脉导管在胸腹主动脉瘤腔内修复术中的应用与安全性
结果显示技术成功率99.1%,无导管相关术中并发症,术后并发症发生率6.9%,无臂部缺血或再次手术。腋动脉导管可安全有效地提供上肢入路,便于输送12F鞘且不中断上肢灌注,工作距离较肱动脉入路更短。
要点
- 腋动脉导管用于胸腹主动脉瘤腔内修复的上肢入路,技术成功率99.1%。
- 无导管相关术中并发症,术后并发症6.9%,无臂部缺血或再次手术。
- 腋动脉导管可输送12F鞘且不中断上肢灌注,工作距离短于肱动脉入路。
核心结论
- 腋动脉导管在复杂主动脉瘤腔内修复中为内脏分支输送提供安全有效的上肢入路。
- 腋动脉导管便于输送12F鞘且不中断上肢灌注,工作距离较肱动脉入路更短。
研究设计与样本
- 29例经锁骨下切口暴露腋动脉并使用腋动脉导管,其中左侧27例、右侧2例。
- 所有病例经导管置入12F鞘输送支架组件;2例采用近端肱动脉入路,1例无需上肢入路。
主要发现
- 腋动脉导管共输送170个支架组件至81个分支和27个开窗,技术成功率99.1%(1个副肾分支未能插管)。
- 无与导管构建或使用相关的术中并发症。
- 术后并发症2例(6.9%)可能归因于导管:1例同侧手无力,1例术后轻微卒中并于首次术后 visit 前缓解。
- 无臂部缺血、伤口血肿或导管相关再次手术。
- 平均随访226天,随访至术后2年。
关键数值与推荐
- 技术成功率99.1%(170个支架组件,81个分支和27个开窗)。
- 术后并发症发生率6.9%(2/29)。
- 所有病例经导管置入12F鞘。
临床怎么用
- 胸腹主动脉瘤腔内修复需上肢入路前向输送内脏分支支架时,可优先考虑腋动脉导管。
- 腋动脉导管可容纳12F鞘且不中断上肢灌注,适合需要较大鞘管的多分支/开窗支架手术。
- 相比肱动脉入路,腋动脉导管提供更短的工作距离,便于支架组件输送。
局限性
- 样本量较小(29例使用腋动脉导管)。
- 平均随访226天,随访时间有限。
- 来自单中心研究者发起的IDE临床试验,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular treatment of thoracoabdominal aortic aneurysms (TAAAs) with branched and fenestrated stent grafts often requires upper extremity arterial access for antegrade delivery of bridging covered stents into the visceral arteries. Axillary, brachial, and radial artery approaches have been described, but data on the safety and utility of the different approaches remain limited. We have preferentially used axillary artery conduits for upper extremity arterial access during endovascular repair of TAAA and describe our technique and report our experience herein. METHODS: Thirty-two patients were treated within an investigator-sponsored investigational device exemption clinical trial of endovascular repair of TAAAs using custom-manufactured stent grafts. In 29 of these cases, the axillary artery was exposed through an infraclavicular incision, and an axillary conduit was used for antegrade delivery of bridging visceral artery stent components. In all cases, a 12F sheath was placed through the conduit for delivery of stent graft components. The left axillary artery was used in 27 of these 29 cases, and the right axillary artery was used in 2 patients. Proximal brachial artery access was used in two patients, and one patient did not require upper extremity access. Aneurysms treated included pararenal (n = 3) and Crawford TAAA extent I (n = 1), extent II (n = 3), extent III (n = 10), and extent IV (n = 15). Patients have been followed up to 2 years after the procedure, with a mean follow-up of 226 days. RESULTS: Axillary conduits were used to deliver a total of 170 stent components placed into 81 branches and 27 fenestrations with 99.1% technical success (one accessory renal branch could not be cannulated). There were no intraoperative complications related to the construction or use of the conduit. There were two postoperative complications (6.9%) potentially attributable to the conduit; one patient experienced ipsilateral hand weakness and one patient had postoperative minor stroke, which resolved by the first postoperative visit. There were no cases of arm ischemia, wound hematoma, or reoperation related to the conduit. CONCLUSIONS: The use of an axillary conduit during endovascular repair of complex aortic aneurysms provides safe and effective upper extremity access for delivery of visceral branches. Moreover, axillary conduits facilitate delivery of 12F sheaths without interrupting upper extremity perfusion and provide a shorter working distance compared with brachial artery approaches.
引用
- Stern JR, Ellozy SH, Connolly PH, et al. Utility and safety of axillary conduits during endovascular repair of thoracoabdominal aneurysms. J Vasc Surg. 2017. PMID: 28259569. doi:10.1016/j.jvs.2016.12.107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。